Profilaxis antimicrobiana en niños con anemia aplásica adquirida

Mónaco, A; Epelbaum, C; Gómez, S; Burgos, M E; Sciuccati, G; Testard, J; Bologna, R; Rosanova, M T.
Med. infant ; 26(4): 373-377, dic. 2019. Tab
Artigo em Espanhol | LILACS | ID: biblio-1047053

Similares

  1. Liposomal amphotericin for secondary prophylaxis: A systematic review and meta-analysis.
  2. Management of Mucormycosis Caused by Rhizopus arrhizus in a Child with Severe Aplastic Anemia and Diabetes Mellitus Undergoing Transplantation.
  3. EFFICACY OF SUBCUTANEOUS IMPLANTS TO PROVIDE CONTINUOUS PLASMA TERBINAFINE IN HELLBENDERS (<i>CRYPTOBRANCHUS ALLEGANIENSI</i>) FOR FUTURE PROPHYLACTIC USE AGAINST CHYTRIDIOMYCOSIS.
  4. Clinical study on empirical and diagnostic-driven (pre-emptive) therapy of voriconazole in severe aplastic anaemia patients with invasive fungal disease after intensive immunosuppressive therapy.
  5. Bridging antifungal prophylaxis with 50 mg or 100 mg micafungin in allogeneic stem cell transplantation: A retrospective analysis.
  6. Is There a Role for Antifungal Prophylaxis in Patients Undergoing Penile Prosthesis Surgery? A Systematic Review.
  7. Posaconazole oral dose and plasma levels in pediatric hematology-oncology patients.
  8. Consensus guidelines for improving patients' understanding of invasive fungal disease and related risk prevention in the haematology/oncology setting, 2021.
  9. Variability of voriconazole concentrations in patients with hematopoietic stem cell transplantation and hematological malignancies: influence of loading dose, procalcitonin, and pregnane X receptor polymorphisms.
  10. An Unusual Cause of Fever and Rash in a Child With Severe Aplastic Anemia.